Ivonescimab monotherapy demonstrated a statistically significant improvement in the trial’s primary endpoint, progression-free survival (PFS) by independent radiologic review committee (IRRC), ...

During the first quarter of 2025, Avantor recorded net sales of $1,581.4 million, with a net income of $64.5 million, ...

Selective Insurance reported a combined ratio of 96.1% for the first quarter of 2025, representing an improvement from the 98 ...

In addition to the financial figures, Dow Inc. reported various significant events subsequent to the first quarter of 2025, ...

Shares of ResMed have moved -0.9% today, and are now trading at a price of $234.09. In contrast, the S&P 500 index saw a 1.0% ...

In terms of production, copper production remained stable compared to the same period last year, with Buenavista’s SX-EW ...

Spire Inc. (NYSE: SR) has made a significant leadership change, appointing Scott Doyle as its new president and chief ...

Northrop Grumman logged a 1.7% change during today's afternoon session, and is now trading at a price of $470.96 per share.

International Business Machines's short interest — meaning the percentage of the share float that is being shorted — is lower ...

In the 10-Q report, RLI Corp. discussed its key performance measures, including underwriting income and combined ratio. For ...

World Kinect Corporation has recently released its 10-Q report, providing a detailed insight into its financial performance ...

Earnings per share, prior to considering any potential adverse impact from the supply chain fraud matter, was $0.95, at the ...